Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Dana-Farber Cancer Institute

11 clinical trials · 11 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Dana-Farber Cancer Institute

RECRUITINGPhase 2NCT05765500

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

This study is testing the way that approved androgen deprivation therapy treatments, Leuprolide and Relugolix, for prostate cancer affect quality of life, blood levels,...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 1103 locations
Prostate CancerProstatic Neoplasms
RECRUITINGEarly Phase 1NCT02172651

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

This study seeks to learn more about the vitamin D receptor and its relationship to colon cancer. The Vitamin D receptor is found in colon cancer cells. When Vitamin D binds to...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 801 location
Stage, Colon CancerStage I-III Colon CancerStage IV Colon Cancer With Resectable Liver Metastases
RECRUITINGPhase 1 / Phase 2NCT04789486

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

This research study is being done to help determine the safety and efficacy of gadolinium based nanoparticle, Activation and Guidance of Irradiation X (AGuIX), used in conjunction...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 1002 locations
Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1
RECRUITINGNCT06543537

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

This research is being done to test a new communication tool for people with ovarian cancer, caregivers, and clinicians. The name of the intervention in this research study is:...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 1121 location
Ovarian CancerOvarian NeoplasmsOvarian Carcinoma
RECRUITINGPhase 2NCT05168930

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

This study is being done to test the effectiveness of zanubrutinib in combination with venetoclax in participants with previously treated chronic lymphocytic leukemia (CLL) or...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 454 locations
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
RECRUITINGPhase 1 / Phase 2NCT03319901

Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

This research study is studying a medication called Venetoclax and a chemotherapy regimen as a possible treatment for Acute Lymphoblastic Leukemia. The drugs involved in this...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 825 locations
Leukemia
RECRUITINGNCT06068075

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

This is a prospective multicenter biomarker study evaluating the prognostic impact of ctDNA detection at diagnosis in patients with Ewing sarcoma or osteosarcoma.

Sponsor: Dana-Farber Cancer InstituteEnrolling: 34015 locations
Ewing SarcomaEwing Sarcoma of BoneEwing Sarcoma of Soft Tissue+4
RECRUITINGNCT03683680

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Sponsor: Dana-Farber Cancer InstituteEnrolling: 2401 location
Mesothelioma
RECRUITINGNCT04115254

Stereotactic Magnetic Resonance Guided Radiation Therapy

This is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 3972 locations
Pancreas CancerLung CancerRenal Cancer+10
RECRUITINGPhase 2NCT05922761

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

The goal of this research study is to test the efficacy of a novel immunosuppressive agent, belumosudil, in allogeneic hematopoietic stem cell transplant (HSCT) recipients who...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 455 locations
Bronchiolitis Obliterans SyndromeBronchiolitis ObliteransLung Diseases+1
RECRUITINGEarly Phase 1NCT06664151

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell...

This study is investigating the effects on immune cells of injecting the influenza vaccine (also known as "flu shot") into cutaneous squamous cell carcinoma (CSCC) tumors prior to...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 252 locations
Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Cutaneous Squamous Cell Cancer